SMTL ID : 1pwm.1

Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 0.92 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 7 residues within 4Å: Chain A: A.46, H.47, V.48, K.78, L.79, W.80, H.111 Ligand excluded by PLIP

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.2: 33 residues within 4Å: Chain A: G.19, T.20, W.21, K.22, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273, C.299 Ligands: FID.3 33 PLIP interactions: 33 interactions with chain A Hydrophobic interactions: A:W.21, A:Y.210, A:Y.210, A:Y.210 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:S.215, A:S.215, A:D.217, A:D.217, A:K.263, A:S.264, A:V.265, A:T.266, A:T.266, A:N.273, A:N.273 Water bridges: A:D.217, A:D.217, A:A.246, A:R.269, A:R.269, A:R.269 Salt bridges: A:K.22, A:K.263, A:R.269 pi-Cation interactions: A:R.269

1 x FID: (2S,4S)-2-AMINOFORMYL-6-FLUORO-SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]-2',5'-DIONE(Non-covalent)

FID.3: 12 residues within 4Å: Chain A: W.21, V.48, Y.49, W.80, H.111, W.112, F.123, W.220, C.299, A.300, L.301 Ligands: NAP.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.21, A:F.123 Hydrogen bonds: A:W.21, A:Y.49, A:H.111, A:L.301 Water bridges: A:L.302, A:L.302 Halogen bonds: A:V.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

El-Kabbani, O. et al., Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors. PROTEINS (2004)

Release Date

2004-02-24

Peptides

aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

aldose reductase

Related Entries With Identical Sequence